ASACOL

This brand name is authorized in United States. It is also authorized in Australia, Canada, Cyprus, Estonia, Finland, Germany, Hong Kong SAR China, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug ASACOL contains one active pharmaceutical ingredient (API):

1	Mesalazine UNII 4Q81I59GXC - MESALAMINE
	Mesalazine is an aminosalicylate. The mechanism of action of mesalazine is not fully understood, but appears to have a topical anti-inflammatory effect on the colonic epithelial cells. Mucosal production of arachidonic acid metabolites, both through the cyclooxygenase and lipoxygenase pathways, is increased in patients with chronic inflammatory bowel disease, and it is possible that mesalazine diminishes inflammation by blocking cyclooxygenase and inhibiting prostaglandin production in the colon.
	Read more about Mesalazine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A07EC02	Mesalazine	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07E Intestinal antiinflammatory agents → A07EC Aminosalicylic acid and similar agents
Discover more medicines within A07EC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11210B, 12463Y
CA	Health Products and Food Branch	02267217
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	06343853, 06344255, 11223186, 11223200, 15619030, 15619047, 17259015, 17259021
EE	Ravimiamet	1146541, 1146574, 1155743, 1184969, 1184970
ES	Centro de información online de medicamentos de la AEMPS	57726, 78448
FI	Lääkealan turvallisuus- ja kehittämiskeskus	008429, 062812, 151589, 156636, 184234, 431473, 434718
GB	Medicines & Healthcare Products Regulatory Agency	175332, 301770, 301774, 301777, 381175, 381176
HK	Department of Health Drug Office	27305, 51118, 51119
IL	מִשְׂרַד הַבְּרִיאוּת	1288, 4910
IT	Agenzia del Farmaco	026416139, 026416141, 026416154, 026416216, 026416230, 026416255, 026416305, 026416317, 026416329
JP	医薬品医療機器総合機構	2399009F3028
LT	Valstybinė vaistų kontrolės tarnyba	1004332, 1004333, 1004551, 1016722, 1021778
MT	Medicines Authority	AA565/00803, AA565/00804, AA565/00805, AA565/00806
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	025M97
NL	Z-Index G-Standaard, PRK	24538, 44954
NZ	Medicines and Medical Devices Safety Authority	15422, 5393, 5394
SG	Health Sciences Authority	03021P, 14275P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699586042058, 8699586043369, 8699586892035, 8699586912047
US	FDA, National Drug Code	0023-5901
ZA	Health Products Regulatory Authority	37/11.1/0629, S/11.10/171, Z/11.10/205, Z/11.10/206